Availability of Dassault Systèmes’ 2014 Half-Year Financial Report (IFRS half year consolidated condensed financial statements Vélizy-Villacoublay, France – July 28, 2014 — Dassault Systèmes (Euronext Paris: #13

Source URL: www.3ds.com

• Dassault Systèmes
• CATIA
• 3ds
• SIMULIA
• Dassault Group
• Exalead
• SolidWorks
• DELMIA
• Vélizy-Villacoublay
• Information technology management
• Product lifecycle management
• Dassault

COMMUNIQUE DE PRESSE Sanofi place un emprunt obligataire de 3 milliards d’euros Paris, France - Le 4 septembre[removed]Sanofi (EURONEXT : SAN et NYSE : SNY) annonce avoir placé avec succès une émission obligataire e

Source URL: www.sanofi.com

PRESS RELEASE Sanofi successfully prices EUR 3 billion bond issue Paris, France - September 4, [removed]Sanofi (EURONEXT: SAN and NYSE: SNY) announces that it has successfully priced its offering of EUR 3 billion of notes

Source URL: en.sanofi.com

• Business
• Investment
• Stock market
• 73rd United States Congress
• Securities
• Securities Act
• Prospectus
• Autorité des marchés financiers
• Euronext
• Financial economics
• United States securities law
• United States Securities and Exchange Commission

PRESS RELEASE Sanofi and Regeneron to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014 Paris, France, and Tarrytown, NY, August 25, [removed]Sanofi (EURONEXT: SAN and NYSE: SNY)

Source URL: en.sanofi.com

• Organofluorides
• Medicine
• Pharmaceutical industry
• Monoclonal antibodies
• Sanofi
• Forward-looking statement
• Ezetimibe
• Pharmaceutical sciences
• Regeneron
• Chemistry

39 rue Cambon[removed]PARIS EURONEXT PARIS NOTICES 11 mai 2005 N° [removed]

Source URL: www.safran-group.com

Dassault Systèmes annonce de bons résultats au deuxième trimestre et confirme ses objectifs financiers pour 2014 VÉLIZY-VILLACOUBLAY, France, le 24 juillet 2014 ─ Dassault Systèmes (Euronext Paris: #13065, DSY.PA)

Source URL: www.3ds.com

PRESS RELEASE Sanofi Discontinues Clinical Development of Investigational JAK2 Agent Fedratinib (SAR302503) Paris, France – November 18, 2013 – Sanofi (EURONEXT: SAN and NYSE: SNY) announced today the decision to ha

Source URL: www.mpnresearchfoundation.org

• Pyrimidines
• Sulfonamides
• TG101348
• Sanofi
• Research
• Clinical trial
• Genzyme
• Science
• Pharmacology
• Pharmaceutical sciences

Dassault Systèmes plant Übernahme der Realtime Technology AG (RTT) Marketing im Zeitalter der Experience Economy STUTTGART/VÉLIZY-VILLACOUBLAY, Frankreich — 5. Dezember 2013 — Dassault Systèmes (Euronext Paris: #

Source URL: www.3ds.com

PRESS RELEASE Cellectis sells its Swedish subsidiary, Cellectis AB, to the Japanese company Takara Bio Inc. July 29, 2014 — Paris, France — Cellectis (Alternext: ALCLS.PA), a leader in the development of adoptive imm

Source URL: www.cellectis.com

• NYSE Euronext
• Anatomy
• Biology
• Biotechnology
• Meganuclease
• Genome engineering
• Immunology
• Immunotherapy
• Cancer immunotherapy
• Medicine
• Immune system
• Cellectis

Dassault Systèmes Reports Solid Second Quarter Performance and Reconfirms Full Year Outlook VÉLIZY-VILLACOUBLAY, France – July 24, 2014 — Dassault Systèmes (Euronext Paris: #13065, DSY.PA), the 3DEXPERIENCE Compan

Source URL: www.3ds.com

• Generally Accepted Accounting Principles
• Financial regulation
• International Financial Reporting Standards
• Dassault Systèmes
• Financial result
• Financial capital
• Asset
• Revenue
• Accountancy
• Finance
• Business